HBSP (USA)
-
Clifford Chance: Mujeres trabajando
Groysberg, Boris; Connolly, Katherine; Marton, StephanieCase HBS-416S13Leadership and People ManagementEra octubre de 2013, y la firma de abogados Clifford Chance mundial venía bajo fuego por segunda vez en menos de un año por supuestamente no proporcionar un ambiente de trabajo propicio para sus asociados femeninos. Un memorando titulado "Hablando con eficacia" se acaba de emitir a las oficinas estadounidenses de la firma y la controversia de inmediato provocado, ya que algunos socios femeninos afirmaron que el asesoramiento específico de género ...Starting at €8.20
-
JPMorgan Chase: Tapping an Overlooked Talent Pool
Groysberg, Boris; Connolly, KatherineCase HBS-415066-ELeadership and People ManagementBy the spring of 2014, the pilot had come to an end for JPMorgan Chase's ReEntry Program, a program designed for women coming back to the workforce after a period of time away. Mary Callahan Erdoes, CEO of Asset Management, and her team had to evaluate whether or not the program had been successful. Participants and managers both had provided some anecdotal positive feedback on the program, but Erdoes wanted to know how they could truly calculate...Starting at €8.20
-
Adaptive Platform Trials: The Clinical Trial of the Future
Stern, Ariel D.; Mehta, SarahCase HBS-618025-EService and Operations ManagementIn July 2017, Dr. Brian M. Alexander, president and CEO of the AGILE Research Foundation, was preparing to launch a new type of clinical trial-an adaptive platform trial-to study potential therapies for glioblastoma (GBM), an aggressive form of brain cancer. Alexander believed that the standard way in which new cancer drugs were tested-the traditional randomized controlled trial (RCT)-was limited in many ways. While statistically rigorous and s...Starting at €8.20
-
Maven Clinic: Women's Health in the Digital Age
Stern, Ariel D.; Mehta, SarahCase HBS-620035-EStrategyIn late 2017, Kate Ryder, the founder and CEO of digital women's health telemedicine company Maven Clinic, faced an important decision. Maven offered both a direct to consumer (D2C) product that anyone could use to book virtual appointments with health practitioners across a range of services and specialties for a fee, and an enterprise product-the Maven Family Benefits platform-which it sold to large employers as an employee benefit. Since found...Starting at €8.20
-
Twine Health
Huckman, Robert S.; Stern, Ariel D.; Preble, MatthewCase HBS-615068-EService and Operations ManagementIn late 2014, Dr. John Moore (CEO), Frank Moss (chairman), and Scott Gilroy (CTO) of Twine Health (Twine) had to resolve several challenges that threatened to restrict the widespread dissemination of its sole product, Twine. Twine was a cloud-based platform that enabled patients to create and manage chronic disease treatment plans in conjunction with their primary care providers and specialized coaches. Twine had already enjoyed impressive succes...Starting at €8.20
-
Adaptive Platform Trials: The Clinical Trial of the Future (B)
Stern, Ariel D.; Mehta, SarahCase HBS-620001-EEntrepreneurshipThis case provides an update to the (A) case, which introduces students to adaptive platform trials, an ambitious, more efficient type of clinical trial that increases access to therapies. The A case centers on Dr. Brian Alexander's efforts to launch an adaptive platform trial for studying potential therapies for glioblastoma (GBM), an aggressive form of brain cancer. The (B) case provides an update and explores the strategies that Alexander is c...Starting at €5.74
-
Clifford Chance: Women at Work
Groysberg, Boris; Connolly, Katherine; Marton, StephanieCase HBS-415038-ELeadership and People ManagementIt was October 2013, and global law firm Clifford Chance was coming under fire for the second time in less than a year for reputedly failing to provide a supportive work environment for its female associates. A memo entitled "Speaking Effectively" was just issued to the U.S. offices of the firm and immediately sparked controversy, as some female associates claimed that the gender-specific advice in the memo was condescending and sexist. This cont...Starting at €8.20